Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
1. Tevogen Bio positions itself as a leader in cost-efficient healthcare. 2. Chinese competitors are accelerating drug development, pressuring US biotech. 3. Health Secretary Robert F. Kennedy Jr. emphasizes affordable healthcare approaches. 4. Tevogen's clinical trials show positive safety data, enhancing product credibility. 5. The company plans to leverage AI for future therapeutic developments.